Medical Devices
Stocks Ranked by
Market Capitalization
| Name | Market cap | Price |
Price change % |
|
|---|---|---|---|---|
126
Adagio Medical Holdings
ADGM
$2.82M
| $2.82M | $0.1026 | 7.4% |
|
127
Vivos Therapeutics
VVOS
$2.69M
| $2.69M | $0.1337 | 0.91% |
|
128
Beyond Air
XAIR
$2.06M
| $2.06M | $2.09 | 9.13% |
|
129
Nexalin Technology
NXL
$1.95M
| $1.95M | $1.86 | 8.37% |
|
130
Tenon Medical
TNON
$1.47M
| $1.47M | $2.20 | 1.79% |
|
131
INVO Fertility Inc
IVF
$1.43M
| $1.43M | $0.5703 | 7% |
|
132
Nuwellis
NUWE
$1.17M
| $1.17M | $0.3221 | 34% |
|
133
Bluejay Diagnostics
BJDX
$605K
| $605K | $0.5850 | 6.97% |
|
|
PFSA
134
Profusa Inc
PFSA
$508K
| $508K | $0.8391 | 17.7% |
|
135
GlucoTrack
GCTK
$410K
| $410K | $0.4032 | 32.7% |
|
Medical Devices Stocks at a Glance
Medical device companies develop surgical equipment, implants, pacemakers, imaging systems, and other therapeutic machines. Procedure volumes drive recurring demand, with regulatory approvals and surgeon adoption creating high switching costs and durable franchises around installed bases.
There are 135 Medical Devices industry stocks tracked by Wall St. Rank, worth a combined $821B.
The largest by market cap are Abbott (ABT) at $179B, Medtronic (MDT) at $122B and Stryker (SYK) at $118B.
Among institutional investors, Alamar Biosciences (ALMR) drew the most net new fund positions in Q2 2026: 87 funds opened new positions.
- Combined market cap: $821B across 135 stocks.
- Largest constituent: Abbott (ABT), $179B market cap.
- Most net new fund positions in Q2 2026: Alamar Biosciences (ALMR), +87 holders.
Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.